Meanings
- uncountablemedicineA medication belonging to the class of Janus kinase inhibitors, used for the treatment of moderate-to-severe plaque psoriasis.
Deucravacitinib (BMS-986165) has shown efficacy in a psoriasis trial (65) and significantly greater American College of Rheumatology 20% improvement rates compared to placebo in patients with PsA.
2021 December, Christine Liu, Jacqueline Kieltyka, Roy Fleischmann, Massimo Gadina, John J. O’Shea, “A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?”, in Arthritis & Rheumatology, volume 73, number 12, →DOI, page 2172
Cite this entry
deucravacitinib. (n.d.). In WatkinsX Dictionary. Retrieved November 4, 2026, from https://dictionary.watkinsx.com/word/deucravacitinib
“deucravacitinib.” WatkinsX Dictionary, https://dictionary.watkinsx.com/word/deucravacitinib. Accessed November 4, 2026.
WatkinsX Dictionary, s.v. “deucravacitinib,” accessed November 4, 2026, https://dictionary.watkinsx.com/word/deucravacitinib.
Source: deucravacitinib on Wiktionary, CC BY-SA 4.0.